Cart
sales@molnova.com
Hydroxythiohomosildenafil
CAS No. 479073-82-0
Hydroxythiohomosildenafil( —— )
Catalog No. M34082 CAS No. 479073-82-0
Hydroxythiohomosildenafil (Sulfohydroxyhomo sildenafil) is a sildenafil analog that may be used to study erectile dysfunction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 414 | In Stock |
|
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxythiohomosildenafil
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxythiohomosildenafil (Sulfohydroxyhomo sildenafil) is a sildenafil analog that may be used to study erectile dysfunction.
-
DescriptionHydroxythiohomosildenafil (Sulfohydroxyhomo sildenafil) is a sildenafil analog that may be used to study erectile dysfunction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number479073-82-0
-
Formula Weight520.67
-
Molecular FormulaC23H32N6O4S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=S(=O)(C=1C=CC(OCC)=C(C1)C2=NC(=S)C3=C(N2)C(=NN3C)CCC)N4CCN(CCO)CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bexmarilimab
Bexmarilimab (FP-1305) is a highly potent, humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM, promoting immune conversion of tumor-associated macrophage phenotype M2 to M1, and can be used to study cancer.
-
Maresin 2
Maresin 2 (3R,14S-diHDHA) is a specialized pro-ablative lipid mediator (SPM) with anti-inflammatory and analgesic activity, promotes mucosal repair, and reduces neutrophil recruitment in yeast polymerase peritonitis.
-
PLH1215
PLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.
